EuroIntervention | Your reference journal for coronary, valvular and structural interventions

Your reference journal for coronary, valvular and structural interventions

Impact of coronary dominance on LM PCI prognosis

Research Correspondence

Feb 9

Impact of coronary dominance on LM PCI prognosis

Yingyang Geng, Lei Song, et al.

This retrospective study found that left-dominant patients undergoing PCI for left main disease had a higher risk of long-term adverse events, particularly target vessel revascularization, compared to non-left-dominant patients.

Research Correspondence

Feb 5

COMPARE trial: 5-year results

Tim Wittig, Sabine Steiner, et al.

The COMPARE trial found no significant difference in 5-year clinically driven target lesion revascularization rates between low-dose and high-dose paclitaxel-coated balloons for the treatment of femoropopliteal lesions in patients with lower limb peripheral artery disease.

Expert Review

Feb 4

3D ICE in structural heart disease

Sergio Berti, Ralph Stephan von Bardeleben, et al.

This expert review discusses the growing importance of intracardiac echocardiography (ICE), particularly 3D ICE, in guiding structural heart interventions due to its ability to provide high-resolution imaging of cardiac anatomy.

free

Editorial

Feb 3

TAVI in small aortic roots

Francesco Maisano

The content discusses the evolution and future of transcatheter aortic valve implantation (TAVI) in the management of aortic stenosis, highlighting the need for further innovation to address unmet needs and enable better lifetime management of patients.

free

Original Research

Feb 2

Biomimetic balloon-expandable THV in SAA

Ole De Backer, Vinayak N. Bapat, et al.

The novel DurAVR transcatheter heart valve demonstrated high technical success, favorable 30-day clinical and hemodynamic outcomes, and a low rate of complications in patients with small aortic annuli.

Biomimetic balloon-expandable THV in SAA

open access

new issue

Feb 2

A new issue of EuroIntervention

An expert review on 3D intracardiac echocardiography; biomimetic balloon-expandable THV in small aortic annuli; intra-annular TAVI in small aortic annuli; 5-year outcomes of transapical transcatheter mitral valve replacement; impact of coronary dominance on left main PCI prognosis; 5-year outcomes of the COMPARE trial; distal foot artery access compression; the retrieval of a stuck TAVI device; and more...

State-of-the-Art

Jan 29

State-of-the-Art collection 2024-2025

EuroIntervention is pleased to share our collection of State-of-the-Art articles from 2024-2025. Join us in looking back on the past two years of high-level insights on key topics of interventional interest, written by top-tier international experts.

Turning Point Podcast

Listen now

Flashlight

Feb 9

Retrieval of a stuck TAVI device

Masakazu Yasuda, Gaku Nakazawa, et al.

A 71-year-old male with schizophrenia and chronic subdural hematoma underwent urgent TAVI using a 26 mm SAPIEN 3 valve via left subclavian access. Prosthesis-balloon alignment failure and balloon rupture occurred, requiring retrieval of the stuck prosthesis and delivery system via the left ventricular apex.

open access

letter to the editor

Jan 30

Letter: Beta blocker withdrawal post-MI

Ahmed B. Shamsulddin

The REBOOT trial confirmed the ischemic safety of withdrawing beta-blockers after successful myocardial infarction treatment, but did not address the impact on patient symptoms and quality of life.

free

letter to the editor

Jan 30

Reply: Beta blocker withdrawal post-MI

Xavier Rossello, Borja Ibanez

The study found that abrupt beta blocker withdrawal in post-MI patients with preserved LVEF is not associated with increased ischemic risk or impaired quality of life.

free

Original Research

Jan 28

Medium-term outcomes in transcatheter PVL closure

Grégoire Albenque, Sebastien Hascoet, et al.

This prospective, multicentre study evaluated medium-term outcomes and predictors of mortality or surgical reintervention after transcatheter paravalvular leak closure in 213 high-risk patients.

Medium-term outcomes in transcatheter PVL closure

Editorial

Jan 27

Residual MPG after TAVI

Tobias Rheude, Héctor Alfonso Alvarez Covarrubias

The ESC/EACTS guidelines recommend TAVI as the preferred treatment for aortic valve stenosis in patients aged ≥70 years, and highlight the importance of multimodal imaging and hemodynamic assessment in predicting structural valve deterioration.

free

Original Research

Jan 26

Structural valve deterioration and mortality after TAVI

Tullio Palmerini, Nazzareno Galiè, et al.

This study found that early residual mean postprocedural gradient after TAVI is an independent predictor of structural valve deterioration, which is associated with high rates of bioprosthetic valve failure and increased 10-year mortality.

Structural valve deterioration and mortality after TAVI

State of the Art

Jan 23

Lesion stratification with IC imaging

Michael McGarvey, Nilesh Pareek, et al.

This article explores how intracoronary imaging can transform the assessment and management of coronary artery disease by enabling detailed lesion characterization, guiding interventional strategies, identifying high-risk plaques, and informing targeted therapies.

free